The present study analyzed a subgroup of participants enrolled in a larger neuroimaging study (Berchio et al.
2017; Murray et al.
2022). Sixteen BPD patients (15 female, mean age: 25.1 ± 5.6) diagnosed with BPD were recruited in a specialized unit of the Department of Psychiatry of the University Hospitals of Geneva. The majority of women in our sample reflects the worldwide overrepresentation of women diagnosed with BPD in specialized units (Sansone and Sansone
2011; Skodol and Bender
2003). A group of 16 age-matched healthy controls (10 female, mean age: 29.6 ± 13.5) were recruited in parallel through announcements in the population. There was no significant difference in gender between the two experimental groups (Table
1). Each participant filled their informed consent prior to the study, which was approved by the Research Ethic Committee of the Republic and Canton of Geneva (CER 13–081).
BPD diagnosis was assessed by the French version of the Structured Clinical Interview for DSM-IV Axis II Disorders BPD part (BPD severity index: M: 7.4, SD = 1.84). Depression was evaluated using the Montgomery-Åsberg Depression Rating Scale (MADRS, Montgomery and Åsberg
1979). In addition, participants completed several self-report questionnaires: the State-Trait Anger Expression Inventory (STAXI, Spielberger
2010), the State-Trait Anxiety Inventory (STAI, Spielberger et al.
1983), the Cognitive Emotion Regulation Questionnaire (CERQ, Jermann et al.
2006), the Affective Lability Scale (ALS, Harvey et al.
1989), the Ruminative Response Scale (RRS, Treynor et al.
2004), the Impulsive Behavior Scale (UPPS, Whiteside et al.
2005), and the Adult Self-Report Scale for ADHD (ASRS, Kessler et al.
2005). We computed sub-scores where relevant: adaptive and maladaptive emotion regulation strategies with the CERQ, rumination and reflection with the RRS, and 4 subscales of the UPPS. The groups differed in: anger and anxiety scores, cognitive non adaptative regulation, affective lability, rumination (except for reflection), impulsive behavior (except sensation seeking), inattention and impulsivity as assessed using ASRS (Table
1). Affective disorders, schizophrenia, and other comorbid conditions in BPD and CTL were assessed using the French version of the Diagnostic Interview for Genetic Studies (DIGS) (Preisig et al.
1999). In BPD patients, current comorbidities included: eating disorders (n = 1), post-traumatic stress disorder (n = 6), anxiety disorder (n = 3), attention-deficit-hyperactivity disorder (n = 2), and substance abuse (n = 5). Comorbidity information was missing for 3 patients. One patient was receiving psychotropic medication (quetiapine). Healthy control subjects had no history of psychiatric illness as assessed with the DIGS, and had no taken medication or substance by their own report.